Abstract
One of the most important places in the pathogenetic therapy of various vascular disorders is occupied by angioprotective, venotonic, antiplatelet, and antithrombotic therapy. In this regard, drugs with a complex effect on various links of vascular disorders are of particular interest. These drugs include AngioNorm®. It is a dry extract obtained from a mixture of medicinal plant raw materials: horse chestnut seeds, licorice roots, hawthorn and rosehip fruits. The combined composition characteristics of the drug extract determine a wide range of its pharmacological activity. The pharmacological properties of the drug, determined by the extract composition, have been confirmed in experimental preclinical and clinical studies which have demonstrated good efficacy, safety and tolerability of therapy in patients with various vascular and microcirculatory disorders (eg. chronic venous insufficiency, hypertension, coronary heart disease, cerebrovascular disease, hemorrhoids, trophic ulcers in the setting of varicose veins, post-infarction conditions, upper limb lymphoedema). The results of clinical studies indicate the possibility of long-term and safe use of this drug in the complex therapy of various vascular lesions in outpatient and inpatient settings KEYWORDS: chronic venous diseases, cardiovascular diseases, microcirculation disorders, angioprotectors, antiplatelet agents, Angionorm. FOR CITATION: Solovyova E.Yu., Abdullaev Sh.P. The use of complex drugs in the treatment of vascular disorders of various origins. Russian Medical Inquiry. 2022;6(8):443–450 (in Russ.). DOI: 10.32364/2587-6821-2022-6-8-443-450.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.